Patients treated with XELJANZ 5 mg twice daily may be switched to XELJANZ XR 11 mg once daily the day following the last dose of XELJANZ 5 mg.
Use of XELJANZ/XELJANZ XR in patients with severe hepatic impairment is not recommended.
Table 1: Dose Adjustments for Lymphopenia 
Table 2: Dose Adjustments for Neutropenia 
Table 3: Dose Adjustments for Anemia 
